Novo Nordisk's CEO took a $1.5 million pay cut in 2024 as the pharma giant's share price tanked and it missed profit and DEI ...

The weight-loss drugmaker's Wegovy and Ozempic are among the most closely watched new medications in recent history, but face ...

Novo Nordisk today announced 2024 earnings, reporting a 26% increase in annual sales to ~$40.56bn. Read why I upgrade NVO ...

We recently published a list of 10 Best Falling Stocks to Invest in Right Now. In this article, we are going to take a look ...

Stocks to Buy or Sell. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other stocks to buy and sell highlighted in Jim Cramer’s latest calls. Jim ...

We came across a bullish thesis on Novo Nordisk A/S (NVO ... Those who saw the potential of tech giants back then are sitting pretty today. AI is at a similar inflection point.

Chief executive Emma Walmsley said ministers must work with the sector to boost investment amid growing concerns about doing ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE ... This rally is built on the back of tariffs, more specifically small-than-expected tariffs that could grow bigger ...

The yearlong downtrend in obesity drug supplier Novo Nordisk (NVO) is potentially over. Last Friday, Jan. 25, NVO stock gained 8.47% to close at $87.97. The company posted the results of its obesity ...

Novo Nordisk is opening a new front in its fight against sickle cell disease, inking a deal with IMMvention Therapeutix to co-develop oral treatments for the red blood cell disorder and other chronic ...

Some say that stocks take the stairs up but the elevator down. While I don’t fully agree with this idea, Novo Nordisk (NVO ... timeframe of up to 24 months. Back in December 2024, Novo completed ...